NCT04160390View on ClinicalTrials.gov

Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant

Active, not recruitingOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

November 13, 2018

Primary Completion Date

April 24, 2027

Study Completion Date

April 24, 2027

Conditions
Allogeneic Hematopoietic Stem Cell Transplant RecipientDonorMalignant Neoplasm
Interventions
OTHER

Biospecimen Collection-Blood

Undergo collection of blood

OTHER

Biospecimen Collection-Stool

Undergo collection of stool

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT04160390 - Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant | Biotech Hunter | Biotech Hunter